The $40 billion investment will be spread across various R&D and manufacturing areas over the next five years.

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) reported Q1 CY2025 results , but sales fell by 5.6% year on year to ...

Bristol Myers Squibb plans to inject $40 billion into U.S. operations over the next five years, mixing business ambition with ...

US pharma major Bristol Myers Squibb is planning a massive $40 billion investment in the country over the next five years.

Bristol Myers Squibb has appointment Cari Gallman as executive vice president, general counsel and chief policy officer, ...

Gallman takes on the role of EVP, General Counsel and Chief Policy Officer, following Sandra Leung’s retirement after 33 ...

A new executive order aims to smooth the path for getting U.S. manufacturing facilities up and running; HHS says it will ...

BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...